225 related articles for article (PubMed ID: 3121363)
1. The antiinflammatory action of guanabenz is mediated through 5-lipoxygenase and cyclooxygenase inhibition.
Chang J; Blazek E; Skowronek M; Marinari L; Carlson RP
Eur J Pharmacol; 1987 Oct; 142(2):197-205. PubMed ID: 3121363
[TBL] [Abstract][Full Text] [Related]
2. SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
Griswold DE; Marshall PJ; Webb EF; Godfrey R; Newton J; DiMartino MJ; Sarau HM; Gleason JG; Poste G; Hanna N
Biochem Pharmacol; 1987 Oct; 36(20):3463-70. PubMed ID: 2823821
[TBL] [Abstract][Full Text] [Related]
3. [Simultaneous and sequential inhibition of the arachidonic acid cascade by inhibitors of phospholipase A2, cyclooxygenase and lipoxygenases in carrageenan edema and adjuvant arthritis in the rat].
Bekemeier H; Hirschelmann R; Ramanampison ML; Pantović D
Pharmazie; 1986 Jun; 41(6):406-8. PubMed ID: 3094043
[TBL] [Abstract][Full Text] [Related]
4. Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo.
Beetens JR; Loots W; Somers Y; Coene MC; De Clerck F
Biochem Pharmacol; 1986 Mar; 35(6):883-91. PubMed ID: 3006695
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of exogenous arachidonic acid on alveolar macrophage 5-lipoxygenase metabolism. Role of ATP depletion.
Peters-Golden M; Shelly C
J Immunol; 1988 Mar; 140(6):1958-66. PubMed ID: 3126237
[TBL] [Abstract][Full Text] [Related]
6. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
7. 2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activity.
Foster SJ; Bruneau P; Walker ER; McMillan RM
Br J Pharmacol; 1990 Jan; 99(1):113-8. PubMed ID: 2110012
[TBL] [Abstract][Full Text] [Related]
8. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.
Carlson RP; O'Neill-Davis L; Chang J; Lewis AJ
Agents Actions; 1985 Dec; 17(2):197-204. PubMed ID: 3938181
[TBL] [Abstract][Full Text] [Related]
9. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
10. Modulation of alveolar macrophage-derived 5-lipoxygenase products by the sulfhydryl reactant, N-ethylmaleimide.
Peters-Golden M; Shelly C
J Biol Chem; 1987 Aug; 262(22):10594-600. PubMed ID: 3112148
[TBL] [Abstract][Full Text] [Related]
11. Suppression of inflammatory responses to 12-O-tetradecanoyl-phorbol-13-acetate and carrageenin by YM-26734, a selective inhibitor of extracellular group II phospholipase A2.
Miyake A; Yamamoto H; Kubota E; Hamaguchi K; Kouda A; Honda K; Kawashima H
Br J Pharmacol; 1993 Sep; 110(1):447-53. PubMed ID: 8220906
[TBL] [Abstract][Full Text] [Related]
12. 1-[4-[3-[4-[bis(4-fluorophenyl)hydroxymethyl]-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone(AHR-5333): a selective human blood neutrophil 5-lipoxygenase inhibitor.
Graff G; Anderson LA
Prostaglandins; 1989 Oct; 38(4):473-96. PubMed ID: 2554366
[TBL] [Abstract][Full Text] [Related]
13. Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models.
Ku EC; Raychaudhuri A; Ghai G; Kimble EF; Lee WH; Colombo C; Dotson R; Oglesby TD; Wasley JW
Biochim Biophys Acta; 1988 Apr; 959(3):332-42. PubMed ID: 2833314
[TBL] [Abstract][Full Text] [Related]
14. Opuntia dillenii cladode: Opuntiol and opuntioside attenuated cytokines and eicosanoids mediated inflammation.
Siddiqui F; Naqvi S; Abidi L; Faizi S; Lubna ; Avesi L; Mirza T; Farooq AD
J Ethnopharmacol; 2016 Apr; 182():221-34. PubMed ID: 26900126
[TBL] [Abstract][Full Text] [Related]
15. [Antiphlogistic effectiveness of combinations of inhibitors of phospholipase A2, cyclooxygenase and lipoxygenases of the arachidonic acid cascade].
Bekemeier H; Hirschelmann R
Pharmazie; 1986 Apr; 41(4):260-2. PubMed ID: 3088612
[TBL] [Abstract][Full Text] [Related]
16. Effect of selected antiinflammatory agents and other drugs on zymosan, arachidonic acid, PAF and carrageenan induced paw edema in the mouse.
Calhoun W; Chang J; Carlson RP
Agents Actions; 1987 Aug; 21(3-4):306-9. PubMed ID: 3120510
[TBL] [Abstract][Full Text] [Related]
17. Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammation.
Carlson RP; O'Neill-Davis L; Calhoun W; Datko L; Musser JH; Kreft AF; Chang JY
Agents Actions; 1989 Mar; 26(3-4):319-28. PubMed ID: 2500009
[TBL] [Abstract][Full Text] [Related]
18. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway.
Liles WC; Meier KE; Henderson WR
J Immunol; 1987 May; 138(10):3396-402. PubMed ID: 3033073
[TBL] [Abstract][Full Text] [Related]
19. FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor.
Blackham A; Griffiths RJ; Hallam C; Mann J; Mitchell PD; Norris AA; Simpson WT
Agents Actions; 1990 Jun; 30(3-4):432-42. PubMed ID: 2117338
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effect of YPE-01, a novel diarylheptanoid derivative, on dermal inflammation in mice.
Yamazaki R; Aiyama R; Matsuzaki T; Hashimoto S; Yokokura T
Inflamm Res; 1998 Apr; 47(4):182-6. PubMed ID: 9628261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
